Barely Significant
← all phrases

“marginally significant”

26,083 sentences · 26,083 papers · 36,483 search hits before verification · confirmed specimen

Sighted at

p>=0.1

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

A significant increase in the crude incidence rate of treatment response was found, over time, for early syphilis episodes (before 2010: 88.5 [75.7–101.3]/1000 PMFU; 2010–2012: 135.8 [117.6–153.9]/1000 PMFU; after 2012: 151.3 [131.1–171.5]/1000 PMFU; P < .0001), whereas a marginally significant increase was observed for late syphilis (before 2010: 61.1 [44.0–78.2]/1000 PMFU; 2010–2012: 94.2 [66.4–122.0]/1000 PMFU; after 2012: 96.9 [59.6–134.1]/1000 PMFU; P = .056).
Nine genes had differences in gene expression between Canton-S B and DGRP_892 across sexes, times, and lighting conditions: AGO2 (FDR = 0.0705; marginally significant, but see below), CG42321 (FDR < 0.0001), Dop1R2 (FDR = 0.0442), GlcT-1 (FDR = 0.0450), GluRIIA (FDR = 0.0141), Mdr65 (FDR = 0.0263), Rae1 (FDR = 0.0206), Tep4 (FDR = 0.0029), and tnc (FDR = 0.0198) (Fig. 4 a–h; Fig.
The variables age, gender, diabetes type, family history, and time by weight and gender by time interactions were statistically nonsignificant in all models, except for time by weight interaction where its p -value marginally significant for subject-specific random intercept and slope model (i.e. linear random effects model).
Effects of MF exposure on circumference of head, up-arm, and abdomen Similar patterns were also observed for head, upper arm, and abdominal circumference, with statistically or marginally significant differences of the above circumferences between girls with higher and lower prenatal MF exposure in all MF exposure measure matrices (TWA, P50 and P75) (Table 4 ).
There was no significant association between the other exposures related to contraception, parity, menopause, hormone replacement therapy, and fertility with all-cause mortality across the survival time intervals; however, there was a marginally significant association between age at menarche >14 years old and mortality in the intermediate survival interval of 6 to <10 years compared to age at menarche ≤12 years old (HR 1.60; 95% CI 1.01, 2.52; p < 0.05).